CSV Q1 2026 Earnings Modest EPS Beat Amid Muted Market Response JELD Q1 2026 Earnings Significant EPS Miss as Company Faces Headwinds PROV Q1 2026 Earnings EPS Misses Estimates by 336 as Bottom Line Disappoints PRH Q1 2026 Earnings Strong EPS Beat Amid Market Uncertainty Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline